Ralf Kettenhofen

1.4k total citations
20 papers, 530 citations indexed

About

Ralf Kettenhofen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ralf Kettenhofen has authored 20 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ralf Kettenhofen's work include Neuroscience and Neural Engineering (14 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Pluripotent Stem Cells Research (5 papers). Ralf Kettenhofen is often cited by papers focused on Neuroscience and Neural Engineering (14 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Pluripotent Stem Cells Research (5 papers). Ralf Kettenhofen collaborates with scholars based in Germany, United States and Switzerland. Ralf Kettenhofen's co-authors include Heribert Bohlen, Agapios Sachinidis, Claudia Seul, H. Vetter, Stefan Seewald, Eugen Kolossov, Yon Ko, Niels Fertig, Michael George and Andrea Brüggemann and has published in prestigious journals such as Journal of Molecular Biology, Biophysical Journal and International Journal of Molecular Sciences.

In The Last Decade

Ralf Kettenhofen

20 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralf Kettenhofen Germany 13 334 243 226 125 43 20 530
Christopher Woods United States 17 453 1.4× 130 0.5× 268 1.2× 125 1.0× 48 1.1× 29 797
Malin K.B. Jonsson Netherlands 16 485 1.5× 229 0.9× 329 1.5× 115 0.9× 115 2.7× 20 695
António Guia United States 11 484 1.4× 286 1.2× 339 1.5× 82 0.7× 24 0.6× 21 640
Donna R. Trollinger United States 8 464 1.4× 148 0.6× 120 0.5× 42 0.3× 36 0.8× 9 666
Marcel M. G. J. van Borren Netherlands 14 453 1.4× 128 0.5× 353 1.6× 74 0.6× 56 1.3× 27 642
Haoyu Zeng United States 14 373 1.1× 242 1.0× 259 1.1× 67 0.5× 34 0.8× 39 553
Alexander R. Harmer United Kingdom 11 279 0.8× 103 0.4× 193 0.9× 48 0.4× 33 0.8× 19 514
Sophie Schobesberger United Kingdom 10 352 1.1× 83 0.3× 308 1.4× 24 0.2× 30 0.7× 16 508
James B. Louttit United Kingdom 5 229 0.7× 151 0.6× 140 0.6× 77 0.6× 51 1.2× 11 494
Marc C. Engels United States 9 341 1.0× 112 0.5× 103 0.5× 37 0.3× 191 4.4× 13 521

Countries citing papers authored by Ralf Kettenhofen

Since Specialization
Citations

This map shows the geographic impact of Ralf Kettenhofen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Kettenhofen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Kettenhofen more than expected).

Fields of papers citing papers by Ralf Kettenhofen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Kettenhofen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Kettenhofen. The network helps show where Ralf Kettenhofen may publish in the future.

Co-authorship network of co-authors of Ralf Kettenhofen

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Kettenhofen. A scholar is included among the top collaborators of Ralf Kettenhofen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Kettenhofen. Ralf Kettenhofen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kettenhofen, Ralf, Benjamin Schmid, Christian Clausen, et al.. (2023). Production of Human Neurogenin 2-Inducible Neurons in a Three-Dimensional Suspension Bioreactor. Journal of Visualized Experiments. 1 indexed citations
2.
Malan, Daniela, Krisztina Juhász, L. Doerr, et al.. (2021). Addendum: Rehnelt et al. Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation. Int. J. Mol. Sci. 2017, 18, 2634. International Journal of Molecular Sciences. 22(11). 5562–5562. 1 indexed citations
3.
Gintant, Gary A., Tromondae K. Feaster, Sonja Stoelzle‐Feix, et al.. (2020). Repolarization studies using human stem cell-derived cardiomyocytes: Validation studies and best practice recommendations. Regulatory Toxicology and Pharmacology. 117. 104756–104756. 36 indexed citations
4.
Kettenhofen, Ralf, et al.. (2020). Voltage-sensing optical recording: A method of choice for high-throughput assessment of cardiotropic effects. Journal of Pharmacological and Toxicological Methods. 105. 106888–106888. 3 indexed citations
5.
Lu, Hua Rong, Haoyu Zeng, Ralf Kettenhofen, et al.. (2019). Assessing Drug-Induced Long QT and Proarrhythmic Risk Using Human Stem-Cell-Derived Cardiomyocytes in a Ca2+ Imaging Assay: Evaluation of 28 CiPA Compounds at Three Test Sites. Toxicological Sciences. 170(2). 345–356. 20 indexed citations
6.
Hu, Ning, Tianxing Wang, Hao Wan, et al.. (2018). Synchronized electromechanical integration recording of cardiomyocytes. Biosensors and Bioelectronics. 117. 354–365. 42 indexed citations
7.
Koci, Bryan, Gregory C. Luerman, Ralf Kettenhofen, et al.. (2017). An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities. Toxicology and Applied Pharmacology. 329. 121–127. 28 indexed citations
8.
Malan, Daniela, Krisztina Juhász, L. Doerr, et al.. (2017). Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation. International Journal of Molecular Sciences. 18(12). 2634–2634. 22 indexed citations
9.
Kettenhofen, Ralf, et al.. (2015). The newcomer is getting up and running: Human iPS cell-derived cardiomyocyte implementation in multiple cardiac safety assessment assays. Journal of Pharmacological and Toxicological Methods. 75. 197–197. 1 indexed citations
10.
Becker, Nadine, Sonja Stoelzle‐Feix, Patrick Mumm, et al.. (2014). Minimized Cell Usage for Stem Cell-Derived and Primary Cells on an Automated Patch Clamp System. Biophysical Journal. 106(2). 135a–135a. 33 indexed citations
11.
Kettenhofen, Ralf, Eugen Kolossov, Simon Hebeisen, et al.. (2013). In vitro pharmacology and safety testing using human iPS-derived Cor.4U cardiomyocytes. Journal of Pharmacological and Toxicological Methods. 68(1). e7–e7. 1 indexed citations
12.
Becker, Nadine, Sonja Stoelzle, Sven Göpel, et al.. (2013). Minimized cell usage for stem cell-derived and primary cells on an automated patch clamp system. Journal of Pharmacological and Toxicological Methods. 68(1). 82–87. 45 indexed citations
13.
Abassi, Yama, Brian Xi, Nan Li, et al.. (2011). Dynamic monitoring of beating periodicity of stem cell‐derived cardiomyocytes as a predictive tool for preclinical safety assessment. British Journal of Pharmacology. 165(5). 1424–1441. 98 indexed citations
14.
Stoelzle, Sonja, Ralf Kettenhofen, Eugen Kolossov, et al.. (2011). Automated Patch Clamp on mESC-Derived Cardiomyocytes for Cardiotoxicity Prediction. SLAS DISCOVERY. 16(8). 910–916. 44 indexed citations
15.
Kettenhofen, Ralf & Heribert Bohlen. (2008). Preclinical assessment of cardiac toxicity. Drug Discovery Today. 13(15-16). 702–707. 33 indexed citations
16.
Kettenhofen, Ralf, et al.. (2001). Regulation of Gadd45a mRNA expression in vascular smooth muscle under growth and stress conditions. Cellular Signalling. 13(11). 787–799. 12 indexed citations
17.
Sachinidis, Agapios, Ralf Kettenhofen, Stefan Seewald, et al.. (1999). Evidence That Lipoproteins Are Carriers of Bioactive Factors. Arteriosclerosis Thrombosis and Vascular Biology. 19(10). 2412–2421. 72 indexed citations
18.
Seewald, Stefan, Claudia Seul, Ralf Kettenhofen, et al.. (1998). Role of Mitogen-Activated Protein Kinase in the Angiotensin II–Induced DNA Synthesis in Vascular Smooth Muscle Cells. Hypertension. 31(5). 1151–1156. 18 indexed citations
19.
Kettenhofen, Ralf, et al.. (1998). Identification of a phosphodiesterase I/Nucleotide pyrophosphatase-related gene mRNA in rat vascular smooth muscle cells by the differential display approach. Journal of Molecular Biology. 279(2). 323–329. 7 indexed citations
20.
Seewald, Stefan, Agapios Sachinidis, Claudia Seul, et al.. (1997). The role of platelet-derived growth factor-BB-induced increase in cytosolic free Ca2+ in activation of mitogen- activated protein kinase and DNA synthesis in vascular smooth muscle cells. Journal of Hypertension. 15(12). 1671–1674. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026